Diagnostics development

Home » What we do » Our science » Diagnostics development

We can help you progress your diagnostic innovations towards clinical use.

Advances in diagnostics can significantly benefit patients, frontline clinicians and healthcare systems.

Our integrated diagnostic team in Edinburgh collaborate with partners on diagnostic projects spanning various platforms and technologies.

Our areas of expertise

All stages of diagnostic development including assay design, diagnostic development, design verification, and clinical validation. 

Mapping clinical and user needs, defining a phased development path that meets regulatory expectations, and facilitating adoption of your developed test.

A development environment certified to ISO 13485, allowing you to build a technical file for regulatory submission.

Strategic links to prospective industry partners and diagnostic platforms and the expertise to determine the best time to engage potential commercial collaborators. 

We’re looking for research projects on: 

  • early detection of disease
  • measurement of worsening or progression of disease
  • companion diagnostics to support treatment decisions
  • digital diagnostics
  • novel biomarkers

Projects should be related to one of the health conditions we address through our Translational Challenges.

Our unique business model

LifeArc staff working through ideas on Post-It notes

As a self-funded charity, we absorb the risk in diagnostics development until industry collaboration is feasible.

At this stage, our business development managers can help you establish new commercial partners for further development of your diagnostic solution.  

Depending on the project, we may receive a share of the future investment return. Exact arrangements are tailored case by case and we offer a range of partnering options. 

Who to contact

Get in touch

Other ways we can support you

Antibody discovery

Innovative single B-cell technologies and clinically-validated platform to generate fully human therapeutic antibodies.

Read more

Antibody humanisation

We can help you optimise and humanise your antibodies with a success rate of more than 98%.

Read more

Targeted protein degradation

PROTACs and alternative E3 ligases to degrade target proteins that aren’t classically targetable by small molecule inhibitors.

Read more
A 3D rendered illustration of proteins

Commercialisation advice

Support your technology transfer to progress your work towards commercially viable products.

Read more

Contact us

Name(Required)
Email(Required)
Please let us know what's on your mind. Have a question for us? Ask away.
This field is for validation purposes and should be left unchanged.

In submitting your personal data via this form, you consent to being contacted via the details provided so that your enquiry can be responded to. If you would like your data to be removed, please email info@lifearc.org.

Please see our Privacy Policy in relation to the personal data you submit to us through this page.

Latest news